Department of Dermatology, Venereology and Allergology, Medical University of Gdansk, 80-214 Gdansk, Poland.
Int J Mol Sci. 2023 Jun 27;24(13):10697. doi: 10.3390/ijms241310697.
Skin adverse reactions to diabetes medical devices have been reported frequently over recent years. Adhesives attaching glucose sensors and continuous insulin infusion sets to the skin are proven to cause both allergic contact dermatitis and irritant contact dermatitis in patients with diabetes mellitus. Several allergens contained in adhesives and/or parts of medical devices are documented to cause allergic contact dermatitis, with acrylate chemicals being the most common culprit-especially isobornyl acrylate (IBOA), but also 2,2'-methylenebis(6-tert-butyl-4-methylphenol) monoacrylate or cyanoacrylates. Epoxy resin, colophonium and nickel were also identified as causative allergens. However, repetitive occlusion, maceration of the skin and resulting disruption of the skin barrier seem to have an impact on the development of skin lesions as well. The purpose of this study is to highlight the burden of contact dermatitis triggered by diabetes medical devices and to show possible mechanisms responsible for the development of contact dermatitis in a group of diabetic patients.
近年来,频繁有报告称糖尿病医疗器械会引发皮肤不良反应。经证实,将葡萄糖传感器和持续胰岛素输注装置粘贴到皮肤上的黏合剂可导致糖尿病患者出现过敏性接触性皮炎和刺激性接触性皮炎。黏合剂和/或医疗器械的某些成分中含有的几种变应原可导致过敏性接触性皮炎,其中丙烯酸盐化学品最为常见,尤其是异冰片丙烯酸酯(IBOA),还有 2,2'-亚甲基双(6-叔丁基-4-甲基苯酚)单丙烯酸酯或氰基丙烯酸酯。环氧树脂、松香和镍也被确定为致病变应原。然而,皮肤的反复封闭、浸渍和由此导致的皮肤屏障破坏似乎也会影响皮肤损伤的发展。本研究旨在强调由糖尿病医疗器械引发的接触性皮炎的负担,并展示一组糖尿病患者发生接触性皮炎的可能机制。